Search Results - "Flipo, R"

Systematic review of the management of canine osteoarthritis by Sandersoln, R. O., Beata, C., Flipo, R-M., Genevois, J-P., Macias, C., Tacke, S., Vezzoni, A., Innes, J. F.

“…This review assesses the evidence for the efficacy of therapies used in the management of osteoarthritis in dogs on the basis of papers published in…”
Get full text

Prevalence of spondyloarthropathies in France: 2001 by Saraux, A, Guillemin, F, Guggenbuhl, P, Roux, C H, Fardellone, P, Le Bihan, E, Cantagrel, A, Chary-Valckenaere, I, Euller-Ziegler, L, Flipo, R-M, Juvin, R, Behier, J-M, Fautrel, B, Masson, C, Coste, J

“…Objective: To estimate the prevalence of spondyloarthropathies (SpAs) in France in a multiregional representative sample in the year 2001. Methods: A two stage…”
Get full text

Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the 'Orencia and Rheumatoid Arthritis' registry by Gottenberg, J E, Ravaud, P, Cantagrel, A, Combe, B, Flipo, R M, Schaeverbeke, T, Houvenagel, E, Gaudin, P, Loeuille, D, Rist, S, Dougados, M, Sibilia, J, Le Loët, X, Marcelli, C, Bardin, T, Pane, I, Baron, G, Mariette, X

“…Very limited data are available regarding the efficacy of abatacept (ABA) in real life. The aims of this study were to determine the efficacy of ABA in…”
Get more information

Prevalence of rheumatoid arthritis in France: 2001 by Guillemin, F, Saraux, A, Guggenbuhl, P, Roux, C H, Fardellone, P, Le Bihan, E, Cantagrel, A, Chary-Valckenaere, I, Euller-Ziegler, L, Flipo, R-M, Juvin, R, Behier, J-M, Fautrel, B, Masson, C, Coste, J

“…Background: Prevalence estimates of rheumatoid arthritis (RA) vary across Europe. Recent estimates in southern European countries showed a lower prevalence…”
Get full text

Predictive factors of change in BMD at 1 and 2 years in women with anorexia nervosa: a study of 146 cases by Legroux-Gérot, I., Vignau, J., d’Herbomez, M., Flipo, R.-M., Cortet, B.

“…Summary Bone mineral density (BMD; measured by DXA) changes were observed at all sites at 1 year in 146 patients with anorexia nervosa. Four independent…”
Get full text

Characteristics and management of olecranon or prepatellar septic bursitis by Nguyen, K., Coquerelle, P., Houvenagel, E., Ducoulombier, V., Senneville, E., Cortet, B., Flipo, R.-M., Salliot, C.

Get full text

Safety of Surgery After Rituximab Therapy in 133 Patients With Rheumatoid Arthritis: Data From the AutoImmunity and Rituximab Registry by Godot, S., Gottenberg, J.‐E., Paternotte, S., Pane, I., Combe, B., Sibilia, J., Flipo, R.‐M., Schaeverbeke, T., Ravaud, P., Toussirot, E., Berenbaum, F., Mariette, X., Wendling, D., Sellam, J.

“…Objective We used data from the AutoImmunity and Rituximab (AIR) registry to investigate the safety of surgery for patients with rheumatoid arthritis receiving…”
Get full text

Predictors of radiographic progression in the ESPOIR cohort: the season of first symptoms may influence the short-term outcome in early arthritis by Mouterde, G, Lukas, C, Logeart, I, Flipo, R M, Rincheval, N, Daurès, J P, Combe, B

“…To determine predictors of short-term radiographic progression in an inception cohort of patients with early arthritis. Patients presenting with synovitis of…”
Get more information

Lack of efficacy of a third tumour necrosis factor α antagonist after failure of a soluble receptor and a monoclonal antibody by SOLAU-GERVAIS, E, LAXENAIRE, N, CORTET, B, DUBUCQUOI, S, DUQUESNOY, B, FLIPO, R.-M

“…Some studies have highlighted the potential benefits of switching from infliximab to etanercept, or after failure of one or the other treatment. To our…”
Get full text

Predictive risk factors of serious infections in patients with rheumatoid arthritis treated with abatacept in common practice: results from the Orencia and Rheumatoid Arthritis (ORA) registry by Salmon, J H, Gottenberg, J E, Ravaud, P, Cantagrel, A, Combe, B, Flipo, R M, Schaeverbeke, T, Houvenagel, E, Gaudin, P, Loeuille, D, Rist, S, Dougados, M, Sibilia, J, Le Loët, X, Meyer, O, Solau-Gervais, E, Marcelli, C, Bardin, T, Pane, I, Baron, G, Perrodeau, E, Mariette, X

“…Little data are available regarding the rate and predicting factors of serious infections in patients with rheumatoid arthritis (RA) treated with abatacept…”
Get more information

ARTIST (osteoarthritis intervention standardized) study of standardised consultation versus usual care for patients with osteoarthritis of the knee in primary care in France: pragmatic randomised controlled trial by Ravaud, P, Flipo, R-M, Boutron, I, Roy, C, Mahmoudi, A, Giraudeau, B, Pham, T

“…Objective To evaluate the impact of standardised consultations on patients with osteoarthritis of the knee.Design Open pragmatic cluster randomised controlled…”
Get full text

Characteristics and management of gout patients in Europe: data from a large cohort of patients by Richette, P, Flipo, R N, Patrikos, D K

“…To increase the knowledge of epidemiology and treatment of gout in a 'real-life' setting, we conducted a large observational analysis (CACTUS) in two European…”
Get more information

Cholesterol crystal embolism mimicking a DRESS by Dumas, M, Flipo, R, Blum, L, Jouzel, C, Brochériou, I, Begon, E

“…Clinical presentation of cholesterol crystal embolism (CCE) can be dermatologic when cholesterol crystals become lodged in small cutaneous arteries resulting…”
Get full text

Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases by Dubucquoi, S, Solau-Gervais, E, Lefranc, D, Marguerie, L, Sibilia, J, Goetz, J, Dutoit, V, Fauchais, A-L, Hachulla, E, Flipo, R-M, Prin, L

“…Background: Anti-filaggrin antibodies (AFA) are among the most specific antibodies for rheumatoid arthritis, so procedures for their detection should be…”
Get full text

Identification of patients with gout: elaboration of a questionnaire for epidemiological studies by Richette, P, Clerson, P, Bouée, S, Chalès, G, Doherty, M, Flipo, R M, Lambert, C, Lioté, F, Poiraud, T, Schaeverbeke, T, Bardin, T

“…In France, the prevalence of gout is currently unknown. We aimed to design a questionnaire to detect gout that would be suitable for use in a telephone survey…”
Get more information

Cysteine and serine proteases of synovial tissue in rheumatoid arthritis and osteoarthritis by Solau-Gervais, E., Zerimech, F., Lemaire, R., Fontaine, C., Huet, G., Flipo, R-M.

“…Objective: To compare the activities of cathepsin B (EC 3.4.22.1) and L (EC 3.4.22.15), calpain (EC 3.4.22.17), and dipeptidyl peptidase (EC 3.4.14.5 or DPP IV…”
Get full text

Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-α antagonist therapy: safe re-initiation of TNF-α blockers after appropriate anti-tuberculous treatment by Denis, B., Lefort, A., Flipo, R.M., Tubach, F., Lemann, M., Ravaud, P., Salmon, D., Mariette, X., Lortholary, O.

“…This study investigated the long-term outcome of patients with tuberculosis (TB) as a complication of tumour necrosis factor (TNF)-α blocker therapy. All TB…”
Get full text

Access and Secondary Use of Data Collected In An Electronic Medical Chart: Results Of The Real World Roswitch Study by Darloy, J, Segaud, N, Baudens, G, Eschard, J, Goeb, V, Salmon, J, Chopin, C, Deprez, X, Houvenagel, E, Idier, I, Gally, S, Pau, D, Flipo, R

“…OBJECTIVES: Secondary use of data to describe in real life the efficacy and the characteristics of Rheumatoid arthritis (RA) patients switching from…”
Get full text

Baseline Characteristics of Rheumatoid Arthritis Patients Starting Certolizumab Pegol Therapy And Glucocorticoid Prescription In The Eclair Study In 2012–2013 by Saraux, A, Flipo, R, Fagnani, F, Bru, I, Cukierman, G, Joubert, J, Czarlewski, W, Dunkel, J, Massol, J, Combe, B

Get full text

Eligibility of rheumatoid arthritis patients for anti-TNF-α therapy according to the 2005 recommendations of the French and British Societies for Rheumatology by Fautrel, B., Flipo, R. M., Saraux, A.

“…Objectives. Several anti-TNF-α prescription guidelines in RA have been published, among which those issued by the British (BSR) and French (SFR) Societies for…”
Get full text